Franz Y. Ho

Groningen, GR 9747AG, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Regulation between LRRK2 and PP2A signaling in cellular models of Parkinson's disease.

Regulation between LRRK2 and PP2A signaling in cellular models of Parkinson's disease.

Journal: The Biochemical journal
Published: March 16, 2026

Condition-dependent amorphous protein agglomerates control cytoplasmic rheology.

Condition-dependent amorphous protein agglomerates control cytoplasmic rheology.

Journal: Molecular cell
Published: July 10, 2025

Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism.

Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism.

Journal: eLife
Published: December 19, 2024

Shrimp allergen extract immunotherapy induces prolonged immune tolerance in a gastro-food allergy mouse model.

Shrimp allergen extract immunotherapy induces prolonged immune tolerance in a gastro-food allergy mouse model.

Journal: PloS one
Published: August 17, 2024

PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner.

PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner.

Journal: Cell death & disease
Published: April 13, 2024

Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization.

Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization.

Journal: ACS chemical neuroscience
Published: May 18, 2023

A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.

A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.

Journal: Cells
Published: December 20, 2021

Allosteric Inhibition of Parkinson's-Linked LRRK2 by Constrained Peptides.

Allosteric Inhibition of Parkinson's-Linked LRRK2 by Constrained Peptides.

Journal: ACS chemical biology
Published: September 09, 2021

The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation.

The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation.

Journal: Brain research
Published: May 28, 2021

Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations.

Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations.

Journal: Bioscience reports
Published: May 20, 2015

Engineering Escherichia coli for functional expression of membrane proteins.

Engineering Escherichia coli for functional expression of membrane proteins.

Journal: Methods in enzymology
Published: April 11, 2015

Revisiting the Roco G-protein cycle.

Revisiting the Roco G-protein cycle.

Journal: The Biochemical journal
Published: October 16, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026